Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID06963567

Observational Registry to Determine Predictors and Outcomes of Patients at Risk of and Diagnosed With Left Ventricular Thrombus

Led by Queen Mary University of London · Updated on 2026-05-06

1500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to better understand left ventricular thrombus (LVT), a blood clot that can form in a weakened heart, especially in people who have had a heart attack or heart failure. About one in six such patients develop these clots, which can lead to serious problems like stroke. The study hopes to gather information on factors linked to clot formation and management to improve care for patients with this condition. Patients included either have a diagnosed LVT with left ventricular dysfunction related to conditions like acute myocardial infarction or cardiomyopathy, or are at risk due to severe heart dysfunction or heart muscle damage. This is an observational study where no treatments are given; instead, participants have routine MRI scans, blood tests, and questionnaires to collect data over time. Participants will provide blood samples at the start and around six months into the study. They will also complete quality of life questionnaires at the beginning and after 12 months. Researchers will record scan results and blood test data and may take additional MRI images during routine scans. The main outcome measured is a composite result assessed from the start to 12 months, with other measures including MRI predictions, blood tests, and quality of life evaluations.

CONDITIONS

Brief Title

Left Ventricular Thrombus Registry

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with left ventricular thrombus
  • Patients at risk for developing left ventricular thrombus, such as those with severe left ventricular dysfunction, left ventricular aneurysm, or myocardial infarction
  • Age 18 years or older
  • Able to give informed consent
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Unable to give informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Baseline

Participants undergo baseline assessments including imaging and blood tests to evaluate left ventricular thrombus status and risk factors.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 12 months (+/- 2 months)

Participants are monitored over time to observe outcomes related to left ventricular thrombus and overall health status.

Follow-up visits at 6 months and 12 months

Trial Site Locations

Total: 1 location

1

St Bartholomew's Hospital

London, United Kingdom, EC1A 7BE

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Assessment of Anti-Coagulation Therapy on Patients With Left...

ST-segment Elevation Myocardial Infarction (STEMI)

Actively Recruiting

1 location

Comparison of Warfarin Versus Rivaroxaban in Management of P...

Left Ventricular Thrombus

Actively Recruiting

1 location

Apixaban Prophylaxis for Prevention of Left Ventricular Thro...

Acute Myocardial Infarction of Anterior Wall

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here